Open access · OA
via OpenAlex
Heartbeat: Inflammatory biomarkers in atrial fibrillation
Heart · 2016 · ▲ 3 citations
Abstract
The association of systemic inflammation with atrial fibrillation and a pro-thrombotic state has received increasing attention recently, but whether this degree of inflammation provides additive value for prediction of clinical outcomes in adults with atrial fibrillation has not been established. In this issue of Heart , Hijazi and colleagues ( see page 508 ) measured inflammatory biomarkers in over 14 thousand patients with atrial fibrillation in the Apixaban for Reduction In Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Cox regression was used to assess the relationship between outcomes at a mean follow-up of 1.9 years and baseline quartile groups of interleukin 6 (IL-6) and C reactive protein (CRP) levels. In these patients with atrial fibrillation who were anti-coagulated with apixaban or warfarin, IL-6 and CRP levels were not associated with an increased risk of stroke or systemic embolism and did not provide additive value to currently utilized risk scores. In contrast, both inflammatory biomarkers were significantly associated with an increased risk for all-cause mortality – the hazard ratio (HR) for IL-6 was 1.93 (1.57 to 2.37) and for CRP was 1.49 (1.24 to 1.79) when comparing the highest and lowest quartiles (figure 1), even after adjustment for clinical factors and other cardiovascular biomarkers.
Figure 1
Cumulative hazard rates for cardiovascular mortality according to quartile groups at baseline of IL-6 (A) and C reactive protein (CRP) (B).
The association of atrial fibrillation and systemic inflammation has clinical implications beyond predicting risk of adverse outcomes. If the risk of systemic embolization is simply …
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1136/heartjnl-2016-309537
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Otto, C.M. (2016). Heartbeat: Inflammatory biomarkers in atrial fibrillation. <em>Heart</em>. https://doi.org/10.1136/heartjnl-2016-309537
Vancouver
Otto CM. Heartbeat: Inflammatory biomarkers in atrial fibrillation. Heart. 2016. doi:10.1136/heartjnl-2016-309537.
BibTeX
@article{catherine2016Heartb,
title = {Heartbeat: Inflammatory biomarkers in atrial fibrillation},
author = {Catherine M Otto},
journal = {Heart},
year = {2016},
doi = {10.1136/heartjnl-2016-309537},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Epigenetics 2018
Open access · CC-BY
Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing
Journal of the American Heart Association 2017
Open access · CC-BY
Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
Frontiers in Nutrition 2025
Open access · CC-BY
The impact of serum uric acid on biological aging and mortality risk: insights from the NHANES and CHARLS cohorts
Journal of clinical medicine 2026
Open access · OA
Systemic Inflammation and Malnutrition Define a High-Risk Phenotype in Chronic Limb-Threatening Ischemia.
Journal of Medicine and Life 2025
Open access · CC-BY
Inflammatory biomarkers for predicting postoperative atrial fibrillation in cardiac surgery
Bioinformation 2026
Open access · CC-BY